Location: United States, North Carolina, Durham
Total raised: $64M
Investors 1
| Date | Name | Website |
| - | Horizon Te... | horizontec... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 08.09.2014 | - | $20M | - |
| 07.01.2013 | - | $24M | - |
| 14.09.2010 | Series D | $20M | - |
Mentions in press and media 15
| Date | Title | Description |
| 08.09.2014 | Tryton Medical Holds Initial Close of $20M PE Financing | Tryton Medical, Inc., a Durham, N.C.-based developer of stents designed to treat coronary bifurcation lesions, held an initial closing of an aggregate $20m private equity financing. Backers included existing investors RiverVest Venture Part... |
| 08.09.2014 | Tryton Medical raises $20M for side-branch stent trial | Tryton Medical said today that’s made an initial closing on a $20 million private equity round from existing and new investors. Durham, N.C.-based Tryton said the round including prior backers RiverVest Venture Partners and 3×5 Special Oppo... |
| 08.09.2014 | Tryton Medical Completes $20M Financing | DURHAM, NC, Leading developer of stents designed to treat coronary bifurcation lesions, today announced an initial closing of an aggregate $20 million private equity financing. >> Click here for more funding data on Tryton Medical ... |
| 11.01.2013 | Durham startup developing stents for bifurcated lesions garners $24 million | Tryton’s Side Branch stent is made of a cobalt chromium alloy. It is placed in the side branch along with a conventional drug-eluting stent in the main vessel. “The company’s innovative stent system for coronary bifurcations is expected to ... |
| 08.01.2013 | Tryton Medical to Raise $24M Financing | Tryton Medical, Inc., a Durham, N.C.-based developer of stents designed to treat bifurcation lesions, held an initial closing of an aggregate $24m financing. Backers included existing investors PTV Sciences, which led the round, RiverVest V... |
| 07.01.2013 | Tryton Medical Completes $24M Equity Round | DURHAM, NC, Leading developer of stents designed to treat bifurcation lesions, today announced an initial closing of an aggregate $24 million financing. >> Click here for more funding data on Tryton Medical >> To export Tryt... |
| 19.05.2011 | Medical device firm Tryton hires new CEO from AngioDynamics | AngioDynamics reported $12.3 million in net income on $216 million in fiscal 2010 revenue from sales of medical products in applications including vascular, oncology and renal treatments. Tryton is a much smaller operation by comparison wit... |
| 18.05.2011 | Stent system from Tryton Medical gets European clearance | Tryton has developed a system to treat bifurcation lesions, a condition where plaque has built up the juncture of a main artery and a side branch. Inserted into the artery, Tryton’s stent system provides support to both the main artery and ... |
| 14.09.2010 | Tryton Medical raises $20 million | The balloon-expandable cobalt chromium-based “side branch stent” is designed to treat bifurcated lesions in cardiac arteries, according to a press release. Private healthcare investor Arnerich Massena led the round and added Russell Rottier... |
| 14.09.2010 | Tryton Medical Closes $20M Series D Round of Financing | Tryton Medical, Inc., a Durham, N.C.-based developer of stents designed to treat bifurcation lesions, has closed a $20m Series D round of financing. The round was led by private healthcare investor Arnerich Massena, with participation from ... |
Show more